This provides a new direction to better understand the cellular and molecular mechanisms of bone response to mechanical stimuli, as well as the roles of key bone regulatory proteins, such as RANKL and sclerostin, which may be the target of anti-osteoporosis drugs. The gene discussed is TNFSF11; the disease is osteoporosis.